PZU:GPWPowszechny Zaklad Ubezpieczen Spolka Akcyjna Analysis

PZU trades at PLN 68.48, essentially at its calculated resistance level of 68.48, while the nearest support sits near 61.70. The stock is riding a bullish MACD signal (line 0.66 above signal 0.10) and a high RSI of 68, suggesting short‑term momentum but also potential overbought conditions. Its valuation metrics show a PE of 9.38 versus an industry average of 17, and a PB of 1.60, indicating relative cheapness, yet the DCF‑derived fair value of ≈ PLN 58.1 places the current price about 4% above intrinsic value, flagging modest overvaluation. Fundamental strength is evident in a solid operating margin of 34.4% and ROE of 18.3%, though revenue is contracting at ‑4.7% YoY; the latest Q1 2026 earnings beat expectations with revenue up 2.3% to PLN 7.8 bn and net profit of PLN 1.4 bn. The balance sheet is cash‑rich (≈ PLN 49.9 bn) but carries sizable debt (≈ PLN 46.2 bn) resulting in a debt‑to‑equity of ≈ 62%, a level that warrants monitoring. With a beta of 0.40 and 30‑day volatility near 23%, the stock exhibits low systematic risk yet moderate price swings, and market sentiment is in “Extreme Greed” territory (FGI 88.5).
Given the neutral trend direction, increasing volume, and the absence of dividend payouts, investors should weigh the upside from earnings momentum against the modest premium to fair value. The combination of strong profitability, a defensive insurance franchise, and limited currency exposure supports a cautious “hold” stance, while the overbought technical profile and slight overvaluation temper enthusiasm for aggressive buying.